Kyowa Kirin Pharmaceutical Development
KYKOYDrugs in Pipeline
23
Phase 3 Programs
17
Upcoming Catalysts
1
Next Catalyst
Aug 2026
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Istradefylline
Parkinson's Disease
OPC-262
Diabetes, Type 2
KHK7580
Parathyroid Carcinoma
Vorinostat
Cutaneous T-Cell Lymphoma
Istradefylline (KW-6002)
Parkinson's Disease
KW-6500
Parkinson's Disease
KHK4827
Psoriasis
Oral Phosphate Supplement
X-Linked Hypophosphatemia
Burosumab
X-linked Hypophosphatemia (XLH)
KW-3357
Disseminated Intravascular Coagulation (DIC)
darbepoetin alfa
Anemia
KHK7791
Hyperphosphatemia
KW-0761
Adult T-cell Leukemia-lymphoma
EN3267
Pain
KRN23
Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
KW-2246 (fentanyl citrate)
Pain, Cancer
Romiplostim
Aplastic Anemia
Mogamulizumab
Cutaneous T-Cell Lymphoma, Relapsed
Pegfilgrastim
Peripheral Blood Stem Cell Transplantation
ARQ 197
Non-small-cell Lung Cancer
KW-6002 (istradefylline)
Parkinson's Disease
KHK4083
Atopic Dermatitis
KW-6356
Parkinson's Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Istradefylline | Phase 3 | Parkinson's Disease | - | - |
OPC-262 | Phase 3 | Diabetes, Type 2 | - | - |
KHK7580 | Phase 3 | Parathyroid Carcinoma | - | - |
Vorinostat | Phase 3 | Cutaneous T-Cell Lymphoma | - | - |
Istradefylline (KW-6002) | Phase 3 | Parkinson's Disease | - | - |
KW-6500 | Phase 3 | Parkinson's Disease | - | - |
KHK4827 | Phase 3 | Psoriasis | - | - |
Oral Phosphate Supplement | Phase 3 | X-Linked Hypophosphatemia | - | - |
Burosumab | Phase 3 | X-linked Hypophosphatemia (XLH) | - | - |
KW-3357 | Phase 3 | Disseminated Intravascular Coagulation (DIC) | - | - |
darbepoetin alfa | Phase 3 | Anemia | - | - |
KHK7791 | Phase 3 | Hyperphosphatemia | - | - |
KW-0761 | Phase 3 | Adult T-cell Leukemia-lymphoma | - | - |
EN3267 | Phase 3 | Pain | - | - |
KRN23 | Phase 3 | Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome | - | - |
KW-2246 (fentanyl citrate) | Phase 3 | Pain, Cancer | - | - |
Romiplostim | Phase 3 | Aplastic Anemia | - | - |
Mogamulizumab | Phase 2 | Cutaneous T-Cell Lymphoma, Relapsed | - | - |
Pegfilgrastim | Phase 2 | Peripheral Blood Stem Cell Transplantation | - | - |
ARQ 197 | Phase 2 | Non-small-cell Lung Cancer | - | - |
KW-6002 (istradefylline) | Phase 2 | Parkinson's Disease | - | - |
KHK4083 | Phase 2 | Atopic Dermatitis | - | - |
KW-6356 | Phase 2 | Parkinson's Disease | - | - |